Skip to main content
Imaging Biometrics Limited logo

Imaging Biometrics Limited — Investor Relations & Filings

Ticker · IBT ISIN · JE00BD4H0R42 LEI · 213800SPW48XRJS2QH57 IL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 23 across all filing types
Latest filing 2026-05-13 Report Publication Anno…
Country JE Jersey
Listing IL IBT

About Imaging Biometrics Limited

https://www.imagingbiometrics.com/

Imaging Biometrics Limited is a medical technology company specializing in the development of automated software solutions for advanced medical imaging analysis. The company's primary focus is on neuro-oncology, providing clinicians and researchers with tools to more accurately characterize and monitor brain tumors. Its product portfolio features proprietary and quantitative technologies, such as Delta T1 (dT1) and relative Cerebral Blood Volume (rCBV) mapping, which are designed to extract more meaningful information from MRI scans. These intuitive software solutions integrate into existing clinical workflows to assist with diagnosis, surgical planning, and the assessment of treatment response, aiming to enhance decision-making and improve patient care.

Recent filings

Filing Released Lang Actions
AMENDEMENT TO NOTICE OF ANNUAL GENERAL MEETING
Report Publication Announcement Classification · 85% confidence The document is a short RNS announcement amending a previously issued Notice of Annual General Meeting (AGM) and stating that the corrected notice will shortly be available on the company website. It does not contain the AGM materials or substantive shareholder voting content itself—rather it announces the publication of a corrected report (the Notice of AGM). Under the “menu vs meal” rule, this is a report publication announcement, not the report itself.
2026-05-13 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information Classification · 85% confidence The document is a short RNS announcement titled “NOTICE OF ANNUAL GENERAL MEETING,” providing date, location, and summary of resolutions for the AGM. It is not a full annual report, proxy statement, or financial results release, but specifically an announcement concerning the AGM itself. Under our taxonomy, this best matches “AGM Information” (AGM-R).
2026-05-12 English
KIRKSTALL AWARDED BBSRC/NC3Rs GRANT: GLIOBLASTOMA
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from Imaging Biometrics Limited about a grant awarded to its subsidiary Kirkstall Limited for a research program on glioblastoma 'tumour on a chip' technology. It details the background, research program, funding, strategic significance, and contact information. There are no financial statements, earnings data, or detailed management analysis. The document is an announcement of a research grant and strategic update rather than a financial report or regulatory filing related to financial performance or governance changes. It is not a report publication announcement since it contains substantive information rather than just a notice of report availability. The content fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-05-08 English
Annual Report for the Year Ended 31 December 2025
Annual Report Classification · 100% confidence The document is titled 'Publication of Annual Report for the Year Ended 31 December 2025' and contains detailed audited financial statements including consolidated income statement, statement of comprehensive income, statement of financial position, and statement of changes in equity for the year ended 31 December 2025. It also includes a CEO statement, business highlights, and detailed notes on operations and financial performance. The document length is substantial (15,000 characters) and contains full financial data and analysis, not just an announcement or summary. Therefore, this is the full Annual Report for the fiscal year ending 31 December 2025, not merely an announcement or a regulatory filing referencing the report. FY 2025
2026-04-30 English
Board Appointment
Board/Management Information Classification · 100% confidence The document is an official announcement from Imaging Biometrics Limited regarding the appointment of a new Non-Executive Director, John Charles Richardson. It details his professional background, current and previous directorships, and confirms compliance with regulatory disclosure requirements. This falls squarely under the definition of a Board/Management Information filing.
2026-02-19 English
Update and IB Nimble Webinar – 27 February 2026
Regulatory Filings Classification · 95% confidence The document is a company update from Imaging Biometrics Limited, dated 11 February 2026, distributed via the Regulatory News Service (RNS) of the London Stock Exchange. It provides a detailed operational and strategic update on the company's projects, market activities, and future outlook. The text includes no financial statements or detailed financial data, nor does it present quarterly or annual financial results. It is not a transcript of a call, nor an announcement of voting results, nor a regulatory certification. The document is a general company update intended for investors and the market, distributed through RNS, which is a common channel for regulatory announcements. Given the nature and length of the document, and the absence of financial statements or detailed financial analysis, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements and company updates that do not fit other specific categories.
2026-02-11 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.